17 Oct 2022
CEO interview with Victoire Viannay
“Fluicell is now taking important steps forward to become a leading force for better health”
In this new interview, published by Stockpicker, CEO Victoire Viannay talks about Fluicell’s plans to create opportunities for better health through precission research tools, tissue-based disease models for drug development and regenerative medicine – all made possible by our high-precision 3D bioprinting platform Biopixlar.
Check it out: https://www.stockpicker.se/home/intervjuer/stockpicker-intervjuar-victoire-viannay-vd-fluicell (in Swedish)